Location: Cluj Napoca
Synced from ClinicalTrials.gov · August 10, 2026
Clinical studies recruiting near Cluj Napoca
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Observational Study Protocol: LIVER-R Phase N/A · AstraZeneca · NCT06252753 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 International Prospective REgistry on Pre-pectorAl Breast REconstruction Phase N/A · IRCCS San Raffaele · NCT05817175 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in Phase 3 · Pfizer · NCT06758401 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) Phase 3 · Bristol-Myers Squibb · NCT07288567 Brief Trial of ACT-i for Adults With Chronic Insomnia NA · Babes-Bolyai University · NCT07048600 Integrating AI in Stroke Neurorehabilitation NA · Eodyne Systems SL · NCT07138495 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS Phase 3 · Eli Lilly and Company · NCT06890598 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Phase N/A · Hoffmann-La Roche · NCT07284121 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer Phase 3 · UroGen Pharma Ltd. · NCT06774131 Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma Phase 1/Phase 2 · Heidelberg Pharma AG · NCT04879043 Efficacy of INM004 in Children With STEC-HUS Phase 3 · Inmunova S.A. · NCT06389474 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone Phase 3 · Celgene · NCT05519085 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac Phase 2 · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi Phase 3 · Amgen · NCT07005128 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc Phase 3 · Boehringer Ingelheim · NCT07220083 Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE) NA · Eodyne Systems SL · NCT06885502 Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic D Phase 2 · Immunovant Sciences GmbH · NCT06979531 Study of SGR-1505 in Mature B-Cell Neoplasms Phase 1 · Schrödinger, Inc. · NCT05544019 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Phase 3 · Eli Lilly and Company · NCT06338995 FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma N Phase 1/Phase 2 · Tubulis GmbH · NCT06303505 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel Phase 3 · AbbVie · NCT04928846 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop Phase 3 · Daiichi Sankyo · NCT06731478 Pan Tumor Rollover Study Phase 2 · Bristol-Myers Squibb · NCT03899155 POS-ARI-ER Observational Study of Acute Respiratory Infections Phase N/A · European Clinical Research Alliance for Infectious Diseases · NCT05814237 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis Phase 3 · Ipsen · NCT06016842 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta Phase 3 · Bristol-Myers Squibb · NCT06561386 Volrustomig Priming Regimens Exploratory Phase II Platform Study Phase 2 · AstraZeneca · NCT06448754 A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A Phase 3 · Novo Nordisk A/S · NCT05685238
Look up another city
Look up another condition
EICHOR